Imiquimod Reverses Chronic Toxoplasmosis-Associated Behavioral and Neurocognitive Anomalies in a Rat Model.

Autor: Itani S; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Hamie M; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., El Jammal R; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Abdine W; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Doumit M; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Charafeddine A; College of Pharmacy, American University of Iraq-Baghdad, Baghdad 10071, Iraq., El-Sabban M; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., Patinote C; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, ENSCM, Université de Montpellier, 34090 Montpellier, France., Masquefa C; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, ENSCM, Université de Montpellier, 34090 Montpellier, France., Bonnet PA; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, ENSCM, Université de Montpellier, 34090 Montpellier, France., Obeid M; Department of Anatomy, Cell Biology and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon., El Hajj H; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.

Publikováno v: Biomedicines [Biomedicines] 2024 Jun 11; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 11.

Imidazo[1,2-a]quinoxalines for melanoma treatment with original mechanism of action.

Autor: Patinote C; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France; Société d'Accélération du Transfert de Technologies (SATT AxLR), CSU, 950 rue Saint Priest, 34090, Montpellier, France., Deleuze-Masquéfa C; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France. Electronic address: carine.masquefa@umontpellier.fr., Kaddour KH; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France., Vincent LA; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France., Larive R; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France., Zghaib Z; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France; Tumorigenèse et Pharmacologie Antitumorale, Lebanese University, EDST, BP 90656, Fanar Jdeideh, Lebanon., Guichou JF; CNRS, UMR 5048, INSERM, U105, Université de Montpellier, Centre de Biochimie Structurale, 34090, Montpellier, France., Assaf MD; Tumorigenèse et Pharmacologie Antitumorale, Lebanese University, EDST, BP 90656, Fanar Jdeideh, Lebanon., Cuq P; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France., Bonnet PA; Institut des Biomolécules Max Mousseron (IBMM), UMR 5247, CNRS, Université de Montpellier, Faculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, 34093, Montpellier Cedex 5, France.

Publikováno v: European journal of medicinal chemistry [Eur J Med Chem] 2021 Feb 15; Vol. 212, pp. 113031. Date of Electronic Publication: 2020 Nov 24.

Substantial Cellular Penetration of Fluorescent Imidazoquinoxalines.

Autor: Patinote C; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France. cindy.patinote@umontpellier.fr., Cirnat N; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France., Hadj-Kaddour K; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France., Cuq P; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France., Bonnet PA; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France., Deleuze-Masquéfa C; IBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.

Publikováno v: Journal of fluorescence [J Fluoresc] 2020 Dec; Vol. 30 (6), pp. 1499-1512. Date of Electronic Publication: 2020 Aug 10.

Synthesis and evaluation of imidazo[1,2-a]quinoxaline derivatives as potential antifungal agents against phytopathogenic fungi.

Autor: Ma T; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Zhong X; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Yang Y; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Liu W; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Guo B; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Fan J; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Tang L; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China., Fan L; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China. fanling1025@126.com., Li Y; Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research On Common Chronic Diseases, College of Pharmacy, Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, 550004, People's Republic of China. liyong19851016@126.com.

Publikováno v: Molecular diversity [Mol Divers] 2024 Oct; Vol. 28 (5), pp. 3153-3163. Date of Electronic Publication: 2023 Oct 17.

Mannosyl thalidomide derivatives for neuinflammation treatment

Autor: Patinote, C., Roscoe, W., Karlik, S., Contino-Pepin, Christine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::47e4241cd1f00c5e33c2f8ad15132fdb
https://hal.archives-ouvertes.fr/hal-01332278